Literature DB >> 21450821

Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein.

Jennifer R Cohen1, Lisa D Lin, Carolyn E Machamer.   

Abstract

The 2003 global outbreak of progressive respiratory failure was caused by a newly emerged virus, severe acute respiratory syndrome coronavirus (SARS-CoV). In contrast to many well-studied enveloped viruses that assemble and bud at the plasma membrane, coronaviruses assemble by budding into the lumen of the endoplasmic reticulum-Golgi intermediate compartment and are released from the cell by exocytosis. For this to occur, the viral envelope proteins must be efficiently targeted to the Golgi region of the secretory pathway. Although the envelope protein (E) makes up only a small percentage of the viral envelope, it plays an important, as-yet-undefined role in virus production. To dissect the targeting of the SARS-CoV E protein to the Golgi region, we exogenously expressed the protein and various mutants from cDNA and determined their localization using immunofluorescence microscopy and biochemical assays. We show that the cytoplasmic tail of the SARS-CoV E protein is sufficient to redirect a plasma membrane protein to the Golgi region. Through site-directed mutagenesis, we demonstrate that a predicted beta-hairpin structural motif in the tail is sufficient for Golgi complex localization of a reporter protein. This motif is conserved in E proteins of beta and gamma coronaviruses (formerly referred to as group 2 and 3 coronaviruses), where it also functions as a Golgi complex-targeting signal. Dissecting the mechanism of targeting of the SARS-CoV E protein will lead to a better understanding of its role in the assembly and release of virions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450821      PMCID: PMC3126292          DOI: 10.1128/JVI.00060-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

2.  The interaction of antibody with the major surface glycoprotein of vesicular stomatitis virus. II. Monoclonal antibodies of nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes.

Authors:  L Lefrancois; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

3.  Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding.

Authors:  J Klumperman; J K Locker; A Meijer; M C Horzinek; H J Geuze; P J Rottier
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  A specific transmembrane domain of a coronavirus E1 glycoprotein is required for its retention in the Golgi region.

Authors:  C E Machamer; J K Rose
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

5.  Cytoplasmic domains of cellular and viral integral membrane proteins substitute for the cytoplasmic domain of the vesicular stomatitis virus glycoprotein in transport to the plasma membrane.

Authors:  L Puddington; C E Machamer; J K Rose
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

Review 6.  Golgi localization of glycosyltransferases: more questions than answers.

Authors:  K J Colley
Journal:  Glycobiology       Date:  1997-02       Impact factor: 4.313

7.  Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication.

Authors:  Lauren Wilson; Peter Gage; Gary Ewart
Journal:  Virology       Date:  2006-07-03       Impact factor: 3.616

8.  Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes.

Authors:  H Vennema; G J Godeke; J W Rossen; W F Voorhout; M C Horzinek; D J Opstelten; P J Rottier
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

9.  The production of recombinant infectious DI-particles of a murine coronavirus in the absence of helper virus.

Authors:  E C Bos; W Luytjes; H V van der Meulen; H K Koerten; W J Spaan
Journal:  Virology       Date:  1996-04-01       Impact factor: 3.616

10.  A highly unusual palindromic transmembrane helical hairpin formed by SARS coronavirus E protein.

Authors:  Eyal Arbely; Ziad Khattari; Guillaume Brotons; Mutaz Akkawi; Tim Salditt; Isaiah T Arkin
Journal:  J Mol Biol       Date:  2004-08-13       Impact factor: 5.469

View more
  32 in total

1.  Nonlytic viral spread enhanced by autophagy components.

Authors:  Sara Whitney Bird; Nathaniel D Maynard; Markus W Covert; Karla Kirkegaard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

2.  Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP.

Authors:  Anirban Ghosh; Amit S Pithadia; Jyotsna Bhat; Supriyo Bera; Anupam Midya; Carol A Fierke; Ayyalusamy Ramamoorthy; Anirban Bhunia
Journal:  Biochemistry       Date:  2015-03-24       Impact factor: 3.162

Review 3.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

4.  Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.

Authors:  Jose A Regla-Nava; Jose L Nieto-Torres; Jose M Jimenez-Guardeño; Raul Fernandez-Delgado; Craig Fett; Carlos Castaño-Rodríguez; Stanley Perlman; Luis Enjuanes; Marta L DeDiego
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

5.  Probing effects of the SARS-CoV-2 E protein on membrane curvature and intracellular calcium.

Authors:  Aujan Mehregan; Sergio Pérez-Conesa; Yuxuan Zhuang; Ahmad Elbahnsi; Diletta Pasini; Erik Lindahl; Rebecca J Howard; Chris Ulens; Lucie Delemotte
Journal:  Biochim Biophys Acta Biomembr       Date:  2022-06-18       Impact factor: 4.019

Review 6.  The Endolysosomal System: The Acid Test for SARS-CoV-2.

Authors:  Daniella Cesar-Silva; Filipe S Pereira-Dutra; Ana Lucia Moraes Giannini; Cecília Jacques G de Almeida
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 7.  The coronavirus E protein: assembly and beyond.

Authors:  Travis R Ruch; Carolyn E Machamer
Journal:  Viruses       Date:  2012-03-08       Impact factor: 5.048

Review 8.  The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.

Authors:  Nicholas A Wong; Milton H Saier
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 6.208

Review 9.  Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.

Authors:  Ritesh Gorkhali; Prashanna Koirala; Sadikshya Rijal; Ashmita Mainali; Adesh Baral; Hitesh Kumar Bhattarai
Journal:  Bioinform Biol Insights       Date:  2021-06-22

10.  A single polar residue and distinct membrane topologies impact the function of the infectious bronchitis coronavirus E protein.

Authors:  Travis R Ruch; Carolyn E Machamer
Journal:  PLoS Pathog       Date:  2012-05-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.